Innovating Works

CHU NANCY

Desconocido
ImmUniverse: Better control and treatment of immune mediated diseases by exploring the universe of microenvironme... CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage Immune-mediated diseases (IMIDs) are an increasing medical burden in industrialized countries worldwide. IMIDs are characterized by an enorm...
2019-12-17 - 2024-12-31 | Financiado
3TR: Identification of the Molecular Mechanisms of non response to Treatments Relapses and Remission in... CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY participó en un H2020: H2020-JTI-IMI2-2018-14-two-stage 3TR is a transdisciplinary consortium made of experts in all areas of medicine, basic sciences and bioinformatics from academic institutions...
2019-08-22 - 2026-08-31 | Financiado
TRACE: Transfer of multivirus specific T cells following transplantation CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY participó en un H2020: H2020-SC1-2016-2017 Allogeneic stem cell transplantation (HSCT) is a curative treatment for a variety of diseases. Viral infections such as Cytomegalovirus (CMV...
2017-12-05 - 2024-03-31 | Financiado
SEYLE: Saving and Empowering Young Lives in Europe Promote health through prevention of risk taking and se... CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY participó en un FP7: Promoting healthy behaviors is multi-faceted and no health is possible without mental health. The ultimate outcome of unhealthy and risk-tak...
Financiado
WE-STAY: Work Toghether to Stop Truancy Among Youth CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY participó en un FP7: Truancy is a serious public health problem that affects adolescents from all countries around the world. In the United States, it has been r...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.